In an exciting collaboration that promises to redefine wound care, Swiss healthcare innovator Healiva has joined forces with the esteemed Lausanne University Hospital (CHUV) to produce their groundbreaking EpiDex autologous epidermis patches. These cutting-edge patches offer renewed hope for patients suffering from chronic wounds by harnessing the power of hair follicle cells.
Healiva’s EpiDex patches are poised to change the game in the treatment of chronic wounds, and this partnership with CHUV marks a significant milestone in bringing this innovative solution to the market.
Revolutionary Healing with EpiDex Patches
EpiDex patches are designed to be a game-changer in the realm of wound care. Developed using a patient’s hair follicle cells, these patches can be applied non-surgically, making the healing process far more accessible and convenient for individuals grappling with chronic wounds. The patches stimulate skin growth, expediting the natural healing process.
Dr. Priyanka Dutta-Passecker, co-founder, and CEO of Healiva, expressed her enthusiasm for the partnership, saying, “We are very pleased to partner with CHUV on EpiDex production. Joining forces with a recognized center of excellence in skin cell therapy marks a major milestone for its market launch.”
A Collaboration of Expertise
The partnership with CHUV enables Healiva to tap into their exceptional knowledge in developing advanced therapy products. This collaboration combines complementary skills in treating both chronic and acute wounds with cell therapy products. Dr. Jean-François Brunet, director of CHUV, highlighted the potential of Healiva’s technology, stating, “Healiva’s technology represents a significant opportunity to change the way we treat people with chronic wounds.”
Healiva’s Multi-Pronged Approach to Wound Care
Healiva stands out for its multi-pronged approach to wound care. Combining enzyme technology, medical devices, and cell therapy, the company is dedicated to tailoring solutions that address various aspects of the wound care spectrum. With this comprehensive strategy, they aim to improve the lives of countless individuals dealing with chronic and acute wounds.
The collaboration between Healiva and CHUV holds the promise of transforming the landscape of wound care. As they work together to manufacture EpiDex patches, patients in Switzerland and beyond can look forward to more effective, accessible, and innovative solutions for their wound healing needs.